Scientific Program
Friday, November 17, 2023
| 09:00-09:10 | Introduction Itamar Raz, Israel, Stefano Del Prato, Italy |
| 09:10- 11:10 | Session 1: Type 1 Diabetes: Future Technologies and Treatments Chairs: Paolo Pozzilli, Italy, Paul Valensi, France, Gilad Twig, Israel |
| 09:10-09:30 | New treatments emerging for type1 diabetes Paolo Pozzilli, Italy |
| 09:30-09:50 | Functional interactions of glucose-lowering drugs with the cardiovascular autonomic system Paul Valensi, France |
| 09:50-10:10 | Treatment of obesity and diabetes with GLP-1 – past, present, and future Daniel Druker, Canada |
| 10:10-10:30 | Cure of T1D Domenico Accili, USA |
| 10:30-10:50 | Roundtable discussion |
| 10:50-11:10 | Coffee Break |
| 11:10-13:10 | Session 2: Present and the Future in Treatment of Diabetes Chairs: Stefano Del Prato, Italy, Gilad Twig, Israel, Eugene Merzon, Israel |
| 11:10-11:30 | Prevention
Ralph Defronzo, USA The talk is sponsored by Ely Lilly, this is an independent sponsorship without control over the content |
| 11:30-11:50 | Cure Stefano Del Prato, Italy |
| 11:50-12:10 | New is good but old is gold Juliana Chan, Hong Kong |
| 12:10-12:30 | Small molecules potentially to prevent T1D Zachary Bloomgarden, USA |
| 12:30-13:10 | Roundtable discussion |
| 13:10-14:10 | Lunch Break |
| 14:10-16:00 | Session 3: Obesity Chairs: Luc Van Gaal, Belgium, Nicola Napoli, Italy |
| 14:10-14:30 | Are mechanisms of weight loss equal in surgery and drugs? Nicola Napoli, Italy |
| 14:30-14:50 | Is there a future for bariatric surgery? Francesco Rubino, UK |
| 14:50-15:10 | Optimizing the Benefits of Metabolic Surgery Lee Kaplan, USA |
| 15:10-15:30 | Long-term cardiovascular effect and mortality Luc Van Gaal, Belgium |
| 15:30-16:00 | Roundtable discussion |
| 16:00-16:10 | Conclusion Stefano Del Prato, Italy |
Saturday, November 18, 2023
| 09:00-11:40 | Session 4: Prevention / Cure of Target Organs Chairs: Francesco Rubino, UK, Alex Miras, Ireland, Gilad Twig, Israel |
| 09:10-09:30 | Clinical strategies for the use and management of combination therapies (both medical and surgical) Napoli Nicola, Italy |
| 09:30-09:50 | Cure – Drugs/Surgery Luc Van Gaal, Belgium |
| 09:50-10:20 | Can drugs replace surgery? Yes – Stefano Del Prato, Italy No – Francesco Rubino, UK |
| 10:20-10:40 | Weight gains after bariatric surgery Drugs- Alex Miras, Ireland |
| 10:40-11:00 | Modular endoscopic bariatric and metabolic therapies: Best of both worlds Barham Abu Dayyeh, USA |
| 11:00-11:20 | Roundtable discussion |
| 11:20-11:40 | Coffee Break |
| 11:40-13:10 | Session 5: Diabetes and CV risk Chairs: Eberhard Standl, Germany, Karsten Kristiansen, Denmark, Francesco Giorgino, Italy |
| 11:40-12:00 | Prevention Hypoglycemia Eberhard Standl, Germany |
| 12:20-12:40 | New pharmacologic approaches for dyslipidemia Italy Anna Solini, Italy |
| 12:40-13:00 | Microbiome Karsten Kristiansen, Denmark |
| 13:00-13:10 | Roundtable discussion |
| 13:10-14:10 | Lunch Break |
| 14:10-16:00 | Session 6: The brain, obesity, and GLP-1 Chairs: Anna Solini, Italy, Tali Cukierman-Yaffe, Israel, Banshi Saboo, Indi |
| 14:10-14:30 | Brain Health & Diabetes Tali Cukierman-Yaffe, Israel |
| 14:30-14:50 | Building on GLP-1 receptor agonism to enhance efficacy and adherence Francesco Giorgino, Italy |
| 14:50-15:10 | Perceptions, attitudes, motivators and barriers among adolescents living with obesity, caregivers and healthcare professionals in Saudi Arabia Hussein Elbadawi, Kingdom of Saudi Arabia |
| 15:10-15:30 | Impact of Glucagon-like peptide-1 (GLP-1) receptor agonists on insulin resistance and weight Merita Emini Sadiku, Kosova |
| 15:30-15:50 | Association between Gestational diabetes and immigration status: A Systematic Review and Meta-analysis Samira Behboudi Gandevani, Norway |
| 15:50-16:00 | Summary and conclusion Francesco Rubino, Italy, Stefano del Prato, Italy |
Sunday, November 19, 2023 – Virtual Program
| 09:00-10:50 | Session 7: Prevention and treatment of target organs |
| 09:00-09:10 | Introduction Itamar Raz, Israel |
| 09:10-09:30 | SGLT2 Lambers Heerspink, Netherlands |
| 09:30-09:50 | The Kidney Gil Chernin, Israel Supported by Bayer |
| 09:50-10:10 | The Liver Rifaat Safadi, Israel |
| 10:10-10:20 | The Heart Pam Taub, USA |
| 10:20-10:35 | Artificial pancreas – Devices to prevent hypoglycemia Ram Weiss, Israel |
| 10:35-10:50 | Prevention of inflammation Roni Weinberg Sibony, Israel |
| 10:50-11:50 | Session 8: T1D |
| 10:50-11:10 | Prevention of T1D Jay Skyler, USA |
| 11:10-11:25 | Prevention of Immune attack on stem cell Matthias Hebrok, USA |
| 11:25-11:40 | CGM interpretation Banshi Saboo, India |
| 11:40-11:55 | Residual Cardiovascular Risk in Type 2 Diavetes: How Long is the Journey Ahead? Ralph DeFronzo, USA |
| 11:55-12:50 | Session 9: Longevity |
| 11:55-12:10 | Old and new approaches in the management of hyperglycemia Antonio Ceriello, Italy |
| 12:10-12:30 | Life extension Einav Gross, Israel |
| 12:30-12:50 | Longevity Nir Barzilai, USA |
| 12:50-13:30 | Lunch Break |
| 13:30-14:50 | Session 10: Obesity |
| 13:30-13:50 | The “weight” of weight loss Richard Pratley, USA |
| 13:50-14:10 | Long-term effect on weight and related diseases Bariatric Surgery Ricardo Cohen, Brazil |
| 14:10-14:30 | Adolescent Obesity, Cognition and Cardiovascular Risk at Adulthood Gilad Twig, Israel |
| 14:30-14:50 | Obesity in the Woman’s Life Cycle Yoel Toledano, Israel |
| 14:50-16:30 | Session 11: Obesity |
| 14:50-15:10 | Multimodal treatment for obesity and diabetes Dimitrios Pournaras, UK |
| 15:10-15:30 | Continue insulin therapy or offer bariatric surgery? Philip Home, UK |
| 15:30-15:50 | Establishing a Population-Based Obesity Registry for Effective Obesity Management in Primary Care Eugene Merzon, Israel |
| 15:50-16:10 | The Cardio Renal Metabolic approach should we treat to prevent Baruch Itzhak, Israel |
| 16:10-16:30 | Summary Stefano Del Prato, Italy, Itamar Raz, Israel |